Natext Biotech Private Limited - Company Profile

It is a chemicals private limited company based in Muambi, Maharashtra, India, established in 2005.
2005 Muambi, Maharashtra, India Struck Off
Last Updated:
Access Report
About Natext Biotech Private Limited

Natext Biotech Private Limited, a struck off private limited company, was established on 03 November 2005 in Muambi, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24234MH2005PTC156487. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.78 M.

It upholds a compliant status. Its leadership includes Pallavi Nilesh Doshi (Director), Rikin Doshi Nilesh (Director). Past directors included Nilesh Khushalchand Doshi, Pallavi Nilesh Doshi, Ranjan Mohan Mogre. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at 6 Maheshwar Niwas44/45 Tilak Rd Santacruz (W), Muambi, Maharashtra, 400054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24234MH2005PTC156487

  • Registration Number

    156487

  • Incorporation Date

    03 November 2005

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.78 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.78 M
  • Company Age 20 Year, 3 Months
  • Last Filing with ROC 31 Mar 2018
Company report

Natext Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Natext Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Natext Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Pallavi Nilesh Doshi Director 31 Jul 2013 Current
Rikin Doshi Nilesh Director 05 Jan 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Aug 2013 Past
Pramod Abcsdd Additional Director 11 Sep 2013 Past
Pramod Abcsdd Additional Director 01 Aug 2011 Past
Pramod Abcsdd Director 05 Jan 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Natext Biotech.

Natext Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Natext Biotech revenue growth over time
Natext Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Natext Biotech?

In 2017, Natext Biotech had a promoter holding of 86.96% and a public holding of 13.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Natext Biotech?

Unlock and access historical data on people associated with Natext Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Natext Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natext Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Natext Biotech
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Natext Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Natext Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Pallavi Nilesh Doshi was appointed as a Director was appointed as a Director on 31 Jul 2013 & has been associated with this company since 12 years 6 months . was documented.

  • Director Appointment

    The activity Rikin Doshi Nilesh was appointed as a Director was appointed as a Director on 05 Jan 2008 & has been associated with this company since 18 years 1 month . was completed.

  • Company Incorporation

    Progress on Natext Biotech Private Limited was registered on 03 Nov 2005 with Roc Mumbai & aged 20 years 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Natext Biotech Private Limited?

The CIN of Natext Biotech Private Limited is U24234MH2005PTC156487.

Where is Natext Biotech Private Limited headquartered?

Natext Biotech Private Limited is headquartered at 6 Maheshwar Niwas44/45 Tilak Rd Santacruz (W), Muambi, Maharashtra, 400054.

When was Natext Biotech Private Limited incorporated?

Natext Biotech Private Limited was incorporated on 03 November 2005.

Who are the current directors of Natext Biotech Private Limited?

The current directors of Natext Biotech Private Limited are

What is the primary industry of Natext Biotech Private Limited?

The primary industry of Natext Biotech Private Limited is Chemicals.

Is Natext Biotech Private Limited a listed company?

Natext Biotech Private Limited is unlisted.

What is the capital structure of Natext Biotech Private Limited?

The authorized capital of Natext Biotech Private Limited is ₹5.00 M, and the paid-up capital is ₹0.78 M.

What is the compliance status of Natext Biotech Private Limited?

The compliance status of Natext Biotech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available